Association between XPF polymorphisms and cancer risk: A meta-analysis

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Shi, Ting Yan ^a,b   He, Jing ^a,b   Qiu, Li Xin ^a,b   Zhu, Mei Ling ^a,b   Wang, Meng Yun ^a,b   Zhou, Xiao Yan ^a,b   Han, Jiali ^c,d   Yu, Hongpin ^e   Zang, Rong Yu ^a,b   Wei, Qingyi ^a,e  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC ERROR; XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP F GENE; BIOSYNTHESIS; FEMALE; GENETICS; GENOTYPE; MALE; META ANALYSIS; METABOLISM; NEOPLASM; REVIEW; RISK FACTOR;

DNA BINDING PROTEIN; TUMOR PROTEIN; XERODERMA PIGMENTOSUM GROUP F PROTEIN;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; MALE; NEOPLASM PROTEINS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84863615742     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038606     Document Type: Article

References (71)

1. Leibeling D, Laspe P, Emmert S, (2006) Nucleotide excision repair and cancer. J Mol Histol 37: 225-238.
2. Wood RD, Mitchell M, Sgouros J, Lindahl T, (2001) Human DNA repair genes. Science 291: 1284-1289.
3. Shields PG, Harris CC, (1991) Molecular epidemiology and the genetics of environmental cancer. JAMA 266: 681-687.
4. Friedberg EC, (2001) How nucleotide excision repair protects against cancer. Nat Rev Cancer 1: 22-33.
5. Liu P, Siciliano J, White B, Legerski R, Callen D, et al. (1993) Regional mapping of human DNA excision repair gene ERCC4 to chromosome 16p13.13-p13.2. Mutagenesis 8: 199-205.
6. Boddy MN, Gaillard PH, McDonald WH, Shanahan P, Yates JR 3rd, et al (2001) Mus81-Eme1 are essential components of a Holliday junction resolvase. Cell 107: 537-548.
7. Nishino T, Komori K, Ishino Y, Morikawa K, (2003) X-ray and biochemical anatomy of an archaeal XPF/Rad1/Mus81 family nuclease: similarity between its endonuclease domain and restriction enzymes. Structure 11: 445-457.
8. Tsodikov OV, Enzlin JH, Scharer OD, Ellenberger T, (2005) Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1. Proc Natl Acad Sci U S A 102: 11236-11241.
9. Tripsianes K, Folkers G, Ab E, Das D, Odijk H, et al. (2005) The structure of the human ERCC1/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair. Structure 13: 1849-1858.
10. Niedernhofer LJ, Odijk H, Budzowska M, van Drunen E, Maas A, et al. (2004) The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol Cell Biol 24: 5776-5787.
11. Ahmad A, Robinson AR, Duensing A, van Drunen E, Beverloo HB, et al. (2008) ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Mol Cell Biol 28: 5082-5092.
12. Doherty JA, Weiss NS, Fish S, Fan W, Loomis MM, et al. (2011) Polymorphisms in Nucleotide Excision Repair Genes and Endometrial Cancer Risk. Cancer Epidemiol Biomarkers Prev 20: 1873-1882.
13. Han J, Haiman C, Niu T, Guo Q, Cox DG, et al. (2009) Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk. Breast Cancer Res Treat 115: 613-622.
14. Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, et al. (2006) Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev 15: 306-311.
15. Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, et al. (2008) International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 17: 3081-3089.
16. Shen MR, Jones IM, Mohrenweiser H, (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-608.
17. Lee SA, Lee KM, Park WY, Kim B, Nam J, et al. (2005) Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer. Exp Mol Med 37: 86-90.
18. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, et al. (2009) Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 125: 1431-1439.
19. Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, et al. (2010) Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control 21: 289-300.
20. Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, et al. (2008) Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer 123: 2095-2104.
21. Crew KD, Gammon MD, Terry MB, Zhang FF, Zablotska LB, et al. (2007) Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16: 2033-2041.
22. Gil J, Ramsey D, Stembalska A, Karpinski P, Pesz KA, et al. (2011) The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep 39: 527-534.
23. Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, et al. (2007) Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat 101: 65-71.
24. Joshi AD, Corral R, Siegmund KD, Haile RW, Le Marchand L, et al. (2009) Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis 30: 472-479.
25. Krupa R, Kasznicki J, Gajecka M, Rydzanicz M, Kiwerska K, et al. (2011) Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population. Exp Oncol 33: 55-56.
26. McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, et al. (2008) Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 68: 4928-4935.
27. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, et al. (2006) Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 27: 1377-1385.
28. Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, et al. (2006) Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 12: 2101-2108.
29. Rajaraman P, Bhatti P, Doody MM, Simon SL, Weinstock RM, et al. (2008) Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists. Int J Cancer 123: 2713-2716.
30. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, et al. (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 12: 37-48.
31. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, et al. (2008) Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29: 2132-2138.
32. Smith TR, Levine EA, Perrier ND, Miller MS, Freimanis RI, et al. (2003) DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12: 1200-1204.
33. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, et al. (2006) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15: 536-542.
34. Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA, (2008) NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Prostate Cancer Prostatic Dis 11: 349-356.
35. Matullo G, Guarrera S, Sacerdote C, Polidoro S, Davico L, et al. (2005) Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 14: 2569-2578.
36. Povey JE, Darakhshan F, Robertson K, Bisset Y, Mekky M, et al. (2007) DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis 28: 1087-1093.
37. Roberts MR, Shields PG, Ambrosone CB, Nie J, Marian C, et al. (2011) Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 32: 1223-1230.
38. Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, et al. (2005) Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 116: 768-773.
39. Wang M, Yuan L, Wu D, Zhang Z, Yin C, et al. (2010) A novel XPF -357A>C polymorphism predicts risk and recurrence of bladder cancer. Oncogene 29: 1920-1928.
40. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, et al. (2009) Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 18: 1610-1616.
41. Yu H, Liu Z, Huang YJ, Yin M, Wang LE, et al. (2011) Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck submitted.
42. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N, (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96: 434-442.
43. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
44. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
45. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
46. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
47. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
48. Duval S, Tweedie R, (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463.
49. Holm K, Melum E, Franke A, Karlsen TH, (2010) SNPexp- A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics 11: 600.
50. Consortium IH, (2003) The International HapMap Project. Nature 426: 789-796.
51. Thorisson GA, Smith AV, Krishnan L, Stein LD, (2005) The International HapMap Project Web site. Genome Res 15: 1592-1593.
52. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315: 848-853.
53. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Chen C, (2006) Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecol Oncol 103: 891-896.
54. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Voigt LF, et al. (2005) Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14: 2524-2530.
55. Smith TR, Liu-Mares W, Van Emburgh BO, Levine EA, Allen GO, et al. (2011) Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer. Carcinogenesis 32: 1354-1360.
56. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, et al. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27: 560-567.
57. Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, et al. (2006) Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis 27: 610-618.
58. Ming-Shiean H, Yu JC, Wang HW, Chen ST, Hsiung CN, et al. (2010) Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk. Ann Surg Oncol 17: 760-771.
59. Milne RL, Ribas G, Gonzalez-Neira A, Fagerholm R, Salas A, et al. (2006) ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping. Cancer Res 66: 9420-9427.
60. Mort R, Mo L, McEwan C, Melton DW, (2003) Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 89: 333-337.
61. Oliveira LGJ, Rinck-Junior JA, Moraes AM, Lima CSP, (2011) The XPC A2920C, The XPF T30028C and the P53 ARG72pro polymorphisms, Involved in DNA repair, Alter the risk for the Malignant Melanoma. European Journal of Cancer 47: S654-S655.
62. Kraemer KH, Lee MM, Andrews AD, Lambert WC, (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130: 1018-1021.
63. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN, (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177-182.
64. Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, et al. (2006) XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol 164: 297-302.
65. Kovacs MS, Hocking DJ, Evans JW, Siim BG, Wouters BG, et al. (1999) Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin. Br J Cancer 80: 1245-1251.
66. Cleaver JE, Lam ET, Revet I, (2009) Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nat Rev Genet 10: 756-768.
67. Lehmann AR, (2003) DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85: 1101-1111.
68. Ding DP, He XF, Zhang Y, (2011) Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies. Breast Cancer Res Treat 129: 203-209.
69. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284.
70. Fung KL, Gottesman MM, (2009) A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta 1794: 860-871.
71. Tsai CJ, Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM, et al. (2008) Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J Mol Biol 383: 281-291.